Onconova Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Newtown PA United States (1998)

Organization Overview

First Clinical Trial
2006
NCT01538563
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Onconova Therapeutics | Onconova Therapeutics, Inc.